Enriched HLA-E and CD94/NKG2a interaction limits anti-tumor CD8+ tumor-infiltrating T lymphocyte responses - Abd Hamid, M; Wang, R; Yao, X; Fan, P; Li, X; Chang, X; Feng, Y; Jones, S; Maldonado-Perez, D; Waugh, C; Verrill, C; Simmons, A; et al. (Wiley, 2019)